EUVIMEDEUVIMED entdecken
Crossref

Nanobody engineering for enhanced-sensitivity rapid COVID-19 tests

Eunji Jeong, Seo Yeong Oh, Seong Uk Son, Sojeong Lee, Ryunhyung Kim, Jaewook Lim, Sunjoo Kim, Taejoon Kang, Juyeon Jung, Seung-Yong Seong, In-Young Jang, Jong Hyun Kim und 4 weitere

Nanoscale · 2025

DOI: 10.1039/d5nr02568k ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Eunji Jeong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul 03722, Republic of Korea. haam@yonsei.ac.kr. Hauptthemen laut MEDLINE: Single-Domain Antibodies, COVID-19, SARS-CoV-2, COVID-19 Testing. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Ministry of Trade, Industry and Energy, Korea Environmental Industry and Technology Institute, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Short description: Nanobody-conjugated gold nanoparticles enabled a highly sensitive SARS-CoV-2 lateral flow assay within 15 minutes, outperforming antibody-based rapid tests and offering strong potential for surveillance and outbreak control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesCOVID-19SARS-CoV-2COVID-19 TestingHumansMetal NanoparticlesGoldImmunoassayLimit of DetectionAntibodies, ViralCoronavirus Nucleocapsid ProteinsSensitivity and SpecificityPoint-of-Care Testing

Substanzen

Single-Domain AntibodiesGoldAntibodies, ViralCoronavirus Nucleocapsid Proteins

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul 03722, Republic of Korea. haam@yonsei.ac.kr.
  • Bionanotechnology Research Center Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea. eklim1112@kribb.re.kr.
  • Department of Nanobiotechnology, KRIBB School, University of Science and Technology (UST), 125 Gwahak-ro, Yuseong-gu, Daejeon 34113, Republic of Korea.
  • Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Changwon 51472, Republic of Korea.
  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Wide River Institute of Immunology, Seoul National University College of Medicine, Hongchon 25159, Republic of Korea.

Förderung

  • Ministry of Trade, Industry and Energy
  • Korea Environmental Industry and Technology Institute
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry
  • Korea Research Institute of Bioscience and Biotechnology

Zitieren

APA

Jeong, E., Oh, S. Y., Son, S. U., Lee, S., Kim, R., Lim, J., Kim, S., Kang, T., Jung, J., Seong, S. Y., Jang, I. Y., Kim, J. H., Jang, E., Jeong, H. H., Lim, E. K., & Haam, S. (2025). Nanobody engineering for enhanced-sensitivity rapid COVID-19 tests. Nanoscale. https://doi.org/10.1039/d5nr02568k

Vancouver

Jeong E, Oh SY, Son SU, Lee S, Kim R, Lim J, et al. Nanobody engineering for enhanced-sensitivity rapid COVID-19 tests. Nanoscale. 2025. doi:10.1039/d5nr02568k

BibTeX
@article{Jeong2025,
  author = {Jeong, Eunji and Oh, Seo Yeong and Son, Seong Uk and Lee, Sojeong and Kim, Ryunhyung and Lim, Jaewook and Kim, Sunjoo and Kang, Taejoon and Jung, Juyeon and Seong, Seung-Yong and Jang, In-Young and Kim, Jong Hyun and Jang, Eunhee and Jeong, Hyoung Hwa and Lim, Eun-Kyung and Haam, Seungjoo},
  title = {Nanobody engineering for enhanced-sensitivity rapid COVID-19 tests},
  journal = {Nanoscale},
  year = {2025},
  doi = {10.1039/d5nr02568k}
}
Kostenlos starten →